FIRST MANHATTAN CO. LLC. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$276,939
+74.4%
28,758
+92.7%
0.00%0.0%
Q2 2023$158,802
+1.1%
14,9250.0%0.00%0.0%
Q1 2023$157,011
-15.1%
14,9250.0%0.00%0.0%
Q4 2022$184,920
+20.1%
14,9250.0%0.00%0.0%
Q3 2022$154,000
-10.5%
14,9250.0%0.00%0.0%
Q2 2022$172,000
-8.0%
14,9250.0%0.00%0.0%
Q1 2022$187,000
+7.5%
14,9250.0%0.00%0.0%
Q4 2021$174,000
-10.3%
14,9250.0%0.00%0.0%
Q3 2021$194,000
+1.0%
14,9250.0%0.00%0.0%
Q2 2021$192,000
+15.7%
14,9250.0%0.00%0.0%
Q1 2021$166,000
-1.8%
14,9250.0%0.00%0.0%
Q4 2020$169,000
+26.1%
14,9250.0%0.00%0.0%
Q3 2020$134,000
-13.0%
14,9250.0%0.00%0.0%
Q2 2020$154,000
+2.7%
14,9250.0%0.00%0.0%
Q1 2020$150,000
-18.9%
14,925
+7.2%
0.00%0.0%
Q4 2019$185,000
-14.7%
13,925
-45.1%
0.00%0.0%
Q3 2019$217,000
-45.3%
25,364
-30.2%
0.00%
-50.0%
Q2 2019$397,000
-25.8%
36,364
-8.1%
0.00%
-33.3%
Q1 2019$535,000
+302.3%
39,564
+206.1%
0.00%
+200.0%
Q4 2018$133,00012,9250.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders